AKASA automates RCM workflows like prior authorization and denial management with generative AI. SmarterDx finds missed diagnoses and undercoding in clinical documentation. They optimize revenue through completely different mechanisms and are best deployed together for maximum impact.
Key Takeaways
- AKASA and SmarterDx address different aspects of revenue optimization
- AKASA automates RCM workflows; SmarterDx finds missed revenue in clinical documentation
- SmarterDx's missed diagnosis detection is a unique capability AKASA does not offer
- Both can be deployed together for comprehensive revenue optimization
- SmarterDx focuses on accuracy; AKASA focuses on efficiency
AKASA wins
AKASA has broader RCM impact, but SmarterDx provides unique CDI value that AKASA cannot replicate.
Feature Comparison
| Feature | AKASA | SmarterDx | Winner |
|---|---|---|---|
| Primary Function | RCM workflow automation | Clinical documentation improvement | Tie |
| AI Application | Generative AI for prior auth, denials | AI for missed diagnosis detection | Tie |
| Revenue Impact | Efficiency gains, denial reduction | Revenue recovery from missed diagnoses | Tie |
| Workflow Scope | Multiple RCM workflows | Clinical documentation only | AKASA |
| Unique Value | Generative AI RCM automation | Missed diagnosis and undercoding detection | Tie |
| Compliance Risk | Standard RCM compliance | Addresses undercoding without upcoding risk | SmarterDx |
AKASA
Best for: Health systems wanting AI automation of RCM workflows like prior auth and denials
Strengths
- +Generative AI RCM automation
- +Multiple workflow coverage
- +Prior auth and denial management
- +Efficiency-driven revenue improvement
Limitations
- -Does not address clinical documentation
- -Cannot find missed diagnoses
- -Enterprise pricing
SmarterDx
Best for: Health systems wanting to find missed revenue in clinical documentation through AI-powered CDI
Strengths
- +Identifies missed diagnoses for revenue recovery
- +Addresses undercoding without upcoding risk
- +Clear ROI from recovered revenue
- +Complements existing CDI programs
Limitations
- -CDI focus only, not full RCM
- -Requires integration with CDI workflows
- -Narrow application scope
Detailed Analysis
RCM BreadthAKASA
AKASA covers multiple RCM workflows. SmarterDx focuses narrowly on clinical documentation improvement.
Revenue RecoveryTie
SmarterDx finds revenue already earned but not captured due to undercoding. AKASA prevents revenue loss through better process efficiency. Different value mechanisms.
Unique CapabilitiesSmarterDx
SmarterDx's missed diagnosis detection is genuinely unique. AKASA's workflow automation has more competitors. SmarterDx's niche is more defensible.
Bottom Line
Deploy both for maximum revenue optimization. AKASA for workflow efficiency and SmarterDx for documentation accuracy. If choosing one, select based on your bigger gap: operational efficiency (AKASA) or documentation completeness (SmarterDx).
Frequently Asked Questions
Can AKASA find missed diagnoses?
No. AKASA automates workflows, not clinical documentation review. SmarterDx's AI specifically identifies conditions present in documentation but not coded.
Can SmarterDx automate prior auth?
No. SmarterDx focuses on clinical documentation improvement. For prior auth automation, AKASA is the appropriate tool.
Which has clearer ROI?
SmarterDx may show clearer ROI because recovered revenue from missed diagnoses is directly measurable. AKASA's ROI comes from efficiency gains and denial reduction.
Do they overlap at all?
Minimally. Both improve revenue but through completely different mechanisms. They complement rather than duplicate each other.